Effectiveness and Safety of Contrast Cryolipolysis for Subcutaneous-Fat Reduction

Table 1

Mean (SD) for fasting glycemia, serum liver test, and serum lipid values.

Analysis (units)	Reference	Time		P value
		Baseline	3 weeks later
Glucose (mg/dL)^a	70-100	85.71 ± 9.04	84.64 ± 10.99	0.862
AST (U/L)^a	10 - 37 ♀ / 11 - 39 ♂	18.96 ± 5.83	21.27 ± 5.90	0.169
ALT (U/L)^a	11 - 45 ♀ / 10 - 37 ♂	17.67 ± 11.96	21.27 ± 8.71	0.136
Cholesterol (mg/dL)^a	< 200	176.4 ± 36.35	166.1 ± 25.54	0.491
Triglycerides (mg/dL)^b	< 200	103 ± 63.16	89.18 ± 57.42	0.765
HDL Cholesterol (mg/dL)^a	> 65	50.65 ± 12.01	47.09 ± 7.22	0.348
LDL Cholesterol (mg/dL)^a	< 130	105.2 ± 30.49	101.2 ± 26.45	0.443
VLDL Cholesterol (mg/dL)^b	< 40	20.59 ± 12.63	17.84 ± 11.48	0.765

ALT, alanine aminotransferase; AST, aspartate aminotransferase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very-low-density lipoprotein.
^aPaired t-test.
^bWilcoxon signed-rank test.
A P-value < 0.05 is considered statistically significant.